Recent Updates
Recently added Catalysts
RXRX

Correction Recursion Provides Business Updates And Reports Second Quarter 2024 Financial Results

Key Takeaway: Correction Recursion Provides Business Updates And Reports Second Quarter 2024 Financial Results
Price reaction · baseline $6.37 (2024-08-07 close) · hit after-hours · clean, no other RXRX news in the window
day 0 close · peak
+4.2%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+65%
120-day peak, hindsight
Typical move
3.8%
average across 3 past catalysts
Cash runway
~15 mo
Low dilution risk
Lead asset
REC-994
Phase 2 · Cerebral Cavernous Malformation

Full Press Release Details

SALT LAKE CITY, Aug. 08, 2024 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by Recursion (Nasdaq: RXRX), please note that in the first bullet under "Additional Corporate Updates", the company's conference call should have been mentioned as having already taken place earlier this morning, rather than coming up later this afternoon as previously stated. The corrected bullet should have read:
• L(earnings) Call:We will host a L(earnings) Call on Aug 8, 2024 at 8:30 am Eastern Time / 6:30 am Mountain Time. We will broadcast the live stream from Recursion’s X (formerly Twitter), LinkedIn, and YouTube accounts and there will be opportunities to ask questions of the company.
The rest of the release remains unchanged.
Last updated: Aug 8, 2024